New mutation in the CYLD gene within a family with Brooke-Spiegler syndrome;Entdeckung einer neuen Mutation im CYLD-Gen bei einer Familie mit Brooke-Spiegler-Syndrom
Cylindromatosis and the CYLD gene: New lessons on the molecular principles of epithelial growth control
Massoumi R, Paus R. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control. BioEssays 2007 29 : 1203 1214.
Familial cutaneous cylindromas: Investigations in five generations of a family
Gerretsen AL, Beemer FA, Deenstra W, Hennekam FA, van Vloten WA. Familial cutaneous cylindromas: Investigations in five generations of a family. J Am Acad Dermatol 1995 33 : 199 206.
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB
Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003 424 : 738 739.
Five new CYLD mutations in skin appendage tumors and evidence that Aspartic Acid 681 in CYLD is essential for deubiquitinase activity
Almeida S, Maillard C, Itin P, Hohl D, Huber M. Five new CYLD mutations in skin appendage tumors and evidence that Aspartic Acid 681 in CYLD is essential for deubiquitinase activity. J Invest Dermatol 2008 128 : 587 593.
An evaluation of the efficacy of topical application of salicylic acid for the treatment of familial cylindromatosis
Oosterkamp HM, Neering H, Nijman SMB, Dirac AMG, Mooi WJ, Bernards R, Brumelkamp TR. An evaluation of the efficacy of topical application of salicylic acid for the treatment of familial cylindromatosis. Br J Dermatol 2006 155 : 182 185.